?

Pharco Corporation - Strategic SWOT Analysis Review

Date: February 3, 2015
Pages: 24
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PFE6470B097EN
Leaflet:

Download PDF Leaflet

Pharco Corporation - Strategic SWOT Analysis Review
Pharco Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Pharco Corporation (Pharco) is a group of healthcare companies. It operates through its eight companies, namely, Pharco Pharmaceuticals, Amriya Pharmaceuticals, European Egyptian Pharmaceuticals, Safe Pharma, Pharco B International, Techno Pharma Egypt, Pharco Impex 93 SRL and Abou Kir Trading. The company along with its subsidiaries develops, manufactures, markets, distributes and exports a wide range of branded and generic drugs; and licensed pharmaceutical products. Its product portfolio includes anti-hypertensive, analgesics, neuroleptic, antiflatulent, skin protectants, anti-allergic, antiparkinsonism, anti-inflammatory, antifungal, multivitamins, minerals, antipyretic, antibiotics, laxative and mucolytic products, among others. The company exports its products to more than 50 countries. Pharco is headquartered in Alexandria, Egypt.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Pharco Corporation - Key Facts
Pharco Corporation - Key Employees
Pharco Corporation - Major Products and Services
Pharco Corporation - History
Pharco Corporation - Company Statement
Pharco Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Pharco Corporation - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Pharco Corporation - Business Description
Pharco Corporation - SWOT Analysis
SWOT Analysis - Overview
Pharco Corporation - Strengths
Strength - Broad Product Offerings
Strength - Focused Research and Development Activities
Strength - Integrated Network of Operations
Strength - Strong Market Position
Pharco Corporation - Weaknesses
Weakness - Locked-up Enterprise Value
Pharco Corporation - Opportunities
Opportunity - Emerging Markets
Opportunity - Growing Incidence of Asthma
Opportunity - Changing Demographics
Opportunity - Growing Demand for Skin Protective Products
Pharco Corporation - Threats
Threat - Increased Scrutiny of Drug Imports
Threat - Competitive Pressures
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Pharco Corporation - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Pharco Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Pharco Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Pharco Corporation, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pharco Corporation, Key Facts
Pharco Corporation, Key Employees
Pharco Corporation, Major Products and Services
Pharco Corporation, History
Pharco Corporation, Subsidiaries
Pharco Corporation, Key Manufacturing Facilities
Pharco Corporation, Key Competitors
Pharco Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Pharco Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Pharco Corporation, Recent Deals Summary

LIST OF FIGURES

Pharco Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Pharco Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Pharco Corporation - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: